---
title: "YIXINTANG established a health management company in Kunming, including medical service business"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232497623.md"
description: "According to the Qichacha APP, recently, YIXINTANG Health Management Co., Ltd. was established, with Ruan Guowei as the legal representative and a registered capital of 5 million yuan. The business scope includes: medical services; catering services; food sales. Qichacha's equity penetration shows that the company is wholly owned by YIXINTANG indirectly"
datetime: "2025-03-20T01:50:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232497623.md)
  - [en](https://longbridge.com/en/news/232497623.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232497623.md)
generator: "portal-rs"
---

# YIXINTANG established a health management company in Kunming, including medical service business

According to the Qichacha APP, recently, YIXINTANG Health Management Co., Ltd. was established, with Ruan Guowei as the legal representative and a registered capital of 5 million yuan. The business scope includes: medical services; catering services; food sales. Qichacha's equity penetration shows that the company is wholly owned by YIXINTANG indirectly

### Related Stocks

- [002727.CN](https://longbridge.com/en/quote/002727.CN.md)

## Related News & Research

- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/298045178.md)
- [Healthcare Firm Breach Exposes 9,540,683 Patient Records – Names, Social Security Numbers, Medical Data and More at Risk](https://longbridge.com/en/news/298030595.md)
- [REG - EDX Medical Group - Director/PDMR shareholdings in the Company](https://longbridge.com/en/news/298058813.md)
- [Finepart wins USD 545,000 Finecut system order from US medtech customer](https://longbridge.com/en/news/298054599.md)
- [Kry rebrands Livi operations under single European brand](https://longbridge.com/en/news/298261214.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**